[go: up one dir, main page]

FI952926L - Förfaranden för behandling och förebyggande av allergies - Google Patents

Förfaranden för behandling och förebyggande av allergies Download PDF

Info

Publication number
FI952926L
FI952926L FI952926A FI952926A FI952926L FI 952926 L FI952926 L FI 952926L FI 952926 A FI952926 A FI 952926A FI 952926 A FI952926 A FI 952926A FI 952926 L FI952926 L FI 952926L
Authority
FI
Finland
Prior art keywords
treating
methods
preventing allergies
allergies
preventing
Prior art date
Application number
FI952926A
Other languages
English (en)
Finnish (fi)
Other versions
FI104465B (sv
FI952926A0 (sv
Inventor
Erika Isolauri
Leena Metsaeniitty
Hannu Korhonen
Seppo Salminen
Eeva-Liisa Syvaeoja
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8543602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI952926(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI952926A priority Critical patent/FI104465B/sv
Publication of FI952926A0 publication Critical patent/FI952926A0/sv
Priority to MYPI96002357A priority patent/MY113912A/en
Priority to AT96918707T priority patent/ATE230606T1/de
Priority to US08/973,963 priority patent/US6506380B1/en
Priority to PL96324010A priority patent/PL185123B1/pl
Priority to KR1019970709383A priority patent/KR100494741B1/ko
Priority to PCT/FI1996/000350 priority patent/WO1997000078A1/en
Priority to DK96918707T priority patent/DK0833649T4/da
Priority to ES96918707T priority patent/ES2191103T5/es
Priority to NZ310478A priority patent/NZ310478A/xx
Priority to CZ19973997A priority patent/CZ291904B6/cs
Priority to CA2224320A priority patent/CA2224320C/en
Priority to CNB961947527A priority patent/CN1154506C/zh
Priority to BR9607827-8A priority patent/BR9607827A/pt
Priority to EP96918707A priority patent/EP0833649B2/en
Priority to JP50267197A priority patent/JP3983804B2/ja
Priority to AU61278/96A priority patent/AU710126C/en
Priority to DE69625690T priority patent/DE69625690T3/de
Priority to SK1715-97A priority patent/SK284245B6/sk
Priority to IL12257796A priority patent/IL122577A0/xx
Priority to EE9700339A priority patent/EE03424B1/xx
Priority to RO97-02328A priority patent/RO120243B1/ro
Priority to ARP960103134A priority patent/AR003960A1/es
Priority to ZA965088A priority patent/ZA965088B/xx
Publication of FI952926L publication Critical patent/FI952926L/sv
Priority to NO19975832A priority patent/NO321504B1/no
Priority to MX9710109A priority patent/MX9710109A/es
Priority to BG102144A priority patent/BG63153B1/bg
Priority to HK98110938A priority patent/HK1010081A1/xx
Publication of FI104465B publication Critical patent/FI104465B/sv
Application granted granted Critical
Priority to US10/321,661 priority patent/US7172756B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI952926A 1995-06-14 1995-06-14 Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa FI104465B (sv)

Priority Applications (29)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (sv) 1995-06-14 1995-06-14 Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa
MYPI96002357A MY113912A (en) 1995-06-14 1996-06-11 Method of preventing or treating allergies
RO97-02328A RO120243B1 (ro) 1995-06-14 1996-06-12 Procedee de preparare a unor formule de hidrolizat proteic, pentru prevenirea sau tratarea alergiilor şi utilizarea acestora
BR9607827-8A BR9607827A (pt) 1995-06-14 1996-06-12 Método para fazer uma fórmula de hidrolisado de proteìna, fórmula de hidrolizado de proteìna,métodos de prevenir ou tratar reações de hipersensibilidade induzidas por alimentos, de tratar alergia a leite de vaca e de promoves respostas tolerogênicas imunes a antìgenos de alimentos.
DE69625690T DE69625690T3 (de) 1995-06-14 1996-06-12 Verfahren zur vorbeugung und behandlung von allergien
PL96324010A PL185123B1 (pl) 1995-06-14 1996-06-12 Sposób wytwarzania mieszanki hydrolizatu białkowego i zastosowanie mieszanki hydrolizatu białkowego
KR1019970709383A KR100494741B1 (ko) 1995-06-14 1996-06-12 알레르기의치료또는예방방법
PCT/FI1996/000350 WO1997000078A1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
DK96918707T DK0833649T4 (da) 1995-06-14 1996-06-12 Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
ES96918707T ES2191103T5 (es) 1995-06-14 1996-06-12 Procedimientos de prevencion o de tratamiento de alergia.
NZ310478A NZ310478A (en) 1995-06-14 1996-06-12 method of making a protein hydrolysate formulation derived by hydrolysing proteins with enzymes from a probiotic gastointestinal bacteria and with pepsin and/or trypsin
CZ19973997A CZ291904B6 (cs) 1995-06-14 1996-06-12 Způsob výroby proteinového hydrolyzátového prostředku, tento prostředek a jeho použití
CA2224320A CA2224320C (en) 1995-06-14 1996-06-12 Method of promoting hypoallergenicity or tolerogenic immune response and compositions therefor
CNB961947527A CN1154506C (zh) 1995-06-14 1996-06-12 预防或治疗过敏的方法
AT96918707T ATE230606T1 (de) 1995-06-14 1996-06-12 Verfahren zur vorbeugung und behandlung von allergien
EP96918707A EP0833649B2 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
JP50267197A JP3983804B2 (ja) 1995-06-14 1996-06-12 アレルギーを予防または治療する方法
AU61278/96A AU710126C (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
US08/973,963 US6506380B1 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
SK1715-97A SK284245B6 (sk) 1995-06-14 1996-06-12 Spôsob výroby proteínového hydrolyzátového prostriedku a jeho použitie
IL12257796A IL122577A0 (en) 1995-06-14 1996-06-12 Methods of preventing or treating allergies
EE9700339A EE03424B1 (et) 1995-06-14 1996-06-12 Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
ARP960103134A AR003960A1 (es) 1995-06-14 1996-06-13 Metodo y medios para suprimir reacciones de hipersensibilidad inducidas por alimentos en pacientes que sufren de alergia a los alimentos
ZA965088A ZA965088B (en) 1995-06-14 1996-06-14 Methods of preventing or treating allergles
NO19975832A NO321504B1 (no) 1995-06-14 1997-12-11 Fremgangsmater for in vitro fremstilling av proteinhydrolysatsammensetning, oral proteinhydrolysatsammensetning og anvendelser derav.
MX9710109A MX9710109A (es) 1995-06-14 1997-12-11 Metodo y medios para suprimir reacciones de hipersensibilidad inducidas por alimentos en pacientes que sufren de alergia a los alimentos.
BG102144A BG63153B1 (bg) 1995-06-14 1997-12-23 Метод за получаване на протеинов хидролизат и използването му за предотвратяване или лечение на алергии
HK98110938A HK1010081A1 (en) 1995-06-14 1998-09-24 Methods of preventing or treating allergies
US10/321,661 US7172756B2 (en) 1995-06-14 2002-12-18 Methods of promoting tolerogenic immune responses and compositions therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI952926A FI104465B (sv) 1995-06-14 1995-06-14 Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa
FI952926 1995-06-14

Publications (3)

Publication Number Publication Date
FI952926A0 FI952926A0 (sv) 1995-06-14
FI952926L true FI952926L (sv) 1996-12-15
FI104465B FI104465B (sv) 2000-02-15

Family

ID=8543602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952926A FI104465B (sv) 1995-06-14 1995-06-14 Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa

Country Status (27)

Country Link
US (2) US6506380B1 (sv)
EP (1) EP0833649B2 (sv)
JP (1) JP3983804B2 (sv)
KR (1) KR100494741B1 (sv)
CN (1) CN1154506C (sv)
AR (1) AR003960A1 (sv)
AT (1) ATE230606T1 (sv)
BG (1) BG63153B1 (sv)
BR (1) BR9607827A (sv)
CA (1) CA2224320C (sv)
CZ (1) CZ291904B6 (sv)
DE (1) DE69625690T3 (sv)
DK (1) DK0833649T4 (sv)
EE (1) EE03424B1 (sv)
ES (1) ES2191103T5 (sv)
FI (1) FI104465B (sv)
HK (1) HK1010081A1 (sv)
IL (1) IL122577A0 (sv)
MX (1) MX9710109A (sv)
MY (1) MY113912A (sv)
NO (1) NO321504B1 (sv)
NZ (1) NZ310478A (sv)
PL (1) PL185123B1 (sv)
RO (1) RO120243B1 (sv)
SK (1) SK284245B6 (sv)
WO (1) WO1997000078A1 (sv)
ZA (1) ZA965088B (sv)

Families Citing this family (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (sv) * 1995-06-14 2000-02-15 Valio Oy Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa
JP2002502430A (ja) * 1997-06-03 2002-01-22 ガネデン バイオテック，インコーポレイテッド Ｓｉｄｓに関連する細菌感染を処置するための共生乳酸細菌
EP1072010B1 (en) 1999-01-19 2010-04-21 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
ATE380033T1 (de) 1999-08-05 2007-12-15 Nestle Sa Bifidobakterien mit der fähigkeit diarrhoe zu verhindern
ATE425244T1 (de) 1999-08-05 2009-03-15 Nestle Sa Bifidobacteria zum vorbeugen von diarrhöe infolge pathogener bakterien
US20020031787A1 (en) * 2000-02-04 2002-03-14 Maclaren Noel K. Compositions and methods for reducing autoimmunity
FI110668B (sv) * 2000-06-20 2003-03-14 Aboatech Ab Oy Användning av probiotika för primärprofylax av atopiska sjukdomar
AU2056102A (en) 2000-09-25 2002-04-02 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
WO2002028402A1 (en) 2000-10-06 2002-04-11 Société des Produits Nestlé S.A. Use of probiotic lactic acid bacteria for balancing the skin's immune system
FI109602B (sv) * 2001-01-25 2002-09-13 Valio Oy Probiotkombination
EP1228707A1 (en) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Use of alpha-lactalbumin as prebiotic agent
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
JP2003137804A (ja) * 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
WO2003102195A1 (en) 2002-06-04 2003-12-11 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
DE60322570D1 (de) 2002-06-28 2008-09-11 Puleva Biotech Sa Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
PT1638416E (pt) 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
WO2005082077A2 (en) 2004-02-25 2005-09-09 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
US20050265946A1 (en) * 2004-05-28 2005-12-01 Kao Corporation Elastase inhibitor
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
RU2428886C2 (ru) 2005-04-13 2011-09-20 Нестек С.А. Смесь для грудных детей, содержащая пробиотики
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
RU2440129C2 (ru) * 2005-11-14 2012-01-20 Нестек С.А. Стимулирование пероральной толерантности гликозилированными белками
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
US9005682B2 (en) 2006-03-07 2015-04-14 Nestec S.A. Synbiotic mixture
ES2403644T3 (es) * 2006-06-15 2013-05-20 Nestec S.A. Inducción de tolerancia a las proteínas de huevo
MX2009009119A (es) * 2007-02-28 2009-09-04 Mead Johnson Nutrition Co Metodo para tratar o prevenir la inflamacion sistemica.
EP1974734A1 (en) † 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974735A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
WO2009029554A2 (en) 2007-08-24 2009-03-05 Codexis, Inc. Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
MY177280A (en) 2008-01-24 2020-09-10 Nestle Sa Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
PT2244734T (pt) 2008-02-01 2016-08-05 Murdoch Childrens Res Inst Método para induzir tolerância a um alérgeno
ES2658837T3 (es) 2008-03-14 2018-03-12 Nestec S.A. Mezcla simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
CA2726850C (en) 2008-06-13 2015-06-02 Codexis, Inc. Method of synthesizing polynucleotide variants
CN102816106A (zh) 2008-06-24 2012-12-12 默沙东公司 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2329013B1 (en) 2008-08-27 2015-10-28 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
DK2385983T3 (en) 2009-01-08 2018-02-12 Codexis Inc Transaminase POLYPEPTIDES
EP2408908B1 (en) 2009-03-17 2015-05-27 Codexis, Inc. Variant endoglucanases and related polynucleotides
CN102428170B (zh) 2009-03-31 2015-03-18 科德克希思公司 改良的内切葡聚糖酶
BRPI1012922A2 (pt) 2009-06-16 2016-10-11 Codexis Inc polipeptídeo de b-glicosidase variante, vetor de expressão, célula hospedeira, método de produção de polipeptídeo de b-glicosidase variante, composição enzimática, método de conversão de um substrato de biomassa em açucar fermentável e método de produção de álcool
EP2446025B1 (en) 2009-06-22 2018-08-08 Codexis, Inc. Ketoreductase-mediated stereoselective route to alpha chloroalcohols
US8614081B2 (en) 2009-07-23 2013-12-24 Codexis, Inc. Nitrilase biocatalysts
MX2012002039A (es) * 2009-08-18 2012-04-11 Nestec Sa Una composicion nutricional que comprende cepas de lactococcus y que reduce los sintomas de la alergia, especialmente en infantes y en niños.
PT2467032T (pt) * 2009-08-18 2018-04-04 Nestec Sa Composição nutricional compreendendo estirpes de bifidobacterium longum e que reduz os sintomas de alergia alimentar, especialmente em lactentes e crianças
EP2467473B1 (en) 2009-08-19 2016-03-23 Codexis, Inc. Ketoreductase polypeptides for the preparation of phenylephrine
CA2772859C (en) 2009-09-04 2015-05-26 Codexis, Inc. Variant cbh2 cellulases and related polynucleotides
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
EP2478137B1 (en) 2009-09-18 2017-09-13 Codexis, Inc. Reduced codon mutagenesis
BR112012012192A2 (pt) 2009-11-25 2017-07-04 Codexis Inc b-glicosidades variantes recombinantes thermoascus aurantiacus para produção de açúcares fermentáveis a partir da biomassa celulósica
DK2504017T3 (en) 2009-11-25 2014-03-03 Codexis Inc RECOMBINANT BETA-glucosidase OPTIONS FOR PRODUCTION OF soluble sugars FROM cellulosic biomass
MX2012006640A (es) 2009-12-08 2012-06-25 Nestec Sa Formula infantil con probioticos y componentes de la membrana del globulo graso de la leche.
SG181535A1 (en) 2009-12-08 2012-07-30 Codexis Inc Synthesis of prazole compounds
CA2786001A1 (en) 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2011140219A1 (en) 2010-05-04 2011-11-10 Codexis, Inc. Biocatalysts for ezetimibe synthesis
JP2013528374A (ja) 2010-05-10 2013-07-11 パーシード セラピューティクス リミテッド ライアビリティ カンパニー Ｖｌａ４のポリペプチド阻害剤
EP2576804B1 (en) 2010-05-28 2016-12-14 Codexis, Inc. Pentose fermentation by a recombinant microorganism
US8852900B2 (en) 2010-06-17 2014-10-07 Codexis, Inc. Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol
US8574878B2 (en) 2010-06-28 2013-11-05 Behnaz Behrouzian Fatty alcohol forming acyl reductases (FARs) and methods of use thereof
CA2803952C (en) 2010-06-30 2020-03-24 Codexis, Inc. Highly stable beta-class carbonic anhydrases useful in carbon capture systems
WO2012024100A2 (en) 2010-08-16 2012-02-23 Merck Sharp & Dohme Corp. Process for preparing aminocyclohexyl ether compounds
WO2012024698A1 (en) 2010-08-20 2012-02-23 Codexis, Inc. Use of glycoside hydrolase 61 family proteins in processing of cellulose
DK2649187T3 (da) 2010-12-08 2018-01-29 Codexis Inc Biokatalysatorer og fremgangsmåder til syntesen af armodafinil
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
WO2012135110A1 (en) 2011-03-30 2012-10-04 Codexis, Inc. Pentose fermentation by a recombinant microorganism
US9102963B2 (en) 2011-04-13 2015-08-11 Codexis, Inc. Biocatalytic process for preparing eslicarbazepine and analogs thereof
UA111078C2 (uk) * 2011-05-03 2016-03-25 Нестек С.А. Гідролізат білкового субстрату і спосіб його виготовлення
WO2013003219A1 (en) 2011-06-30 2013-01-03 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2748317B1 (en) 2011-08-22 2017-04-19 Codexis, Inc. Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity
US9109209B2 (en) 2011-09-08 2015-08-18 Codexis, Inc. Biocatalysts and methods for the synthesis of substituted lactams
EP2760997A4 (en) 2011-09-30 2015-02-11 Codexis Inc MUSHROOM PROTEASE
WO2013052101A1 (en) * 2011-10-03 2013-04-11 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
US9139819B2 (en) 2011-11-18 2015-09-22 Codexis, Inc. Biocatalysts for the preparation of hydroxy substituted carbamates
BR112014015030A2 (pt) 2011-12-20 2017-06-13 Codexis Inc variantes da endoflucanase 1b (eg1b)
CN104508126B (zh) 2012-03-23 2017-06-30 科德克希思公司 用于合成色胺和色胺类似物的衍生物的生物催化剂和方法
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
CN107699548B (zh) 2012-05-08 2021-10-22 科德克希思公司 用于化合物的羟基化的生物催化剂和方法
WO2013170050A1 (en) 2012-05-11 2013-11-14 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
BR112014031026A2 (pt) 2012-06-11 2017-06-27 Codexis Inc variantes de beta-xilosidase fúngica.
BR112015011466A8 (pt) 2012-11-20 2018-05-02 Codexis Inc Célula hospedeira fúngica recombinante, constructo de ácido nucleico recombinante, sequência de polpeptídeo isolada, e, métodos para produzir um produto de fermentação e pelo menos um produto final a partir de pelo menos um substrato celulósico
PT2928865T (pt) 2012-12-07 2018-06-11 Merck Sharp & Dohme Processo de transaminação biocatalítica
JP6618180B2 (ja) 2012-12-21 2019-12-11 コデクシス， インコーポレイテッド キラルアミンを合成するための操作された生体触媒および方法
JP6486835B2 (ja) 2013-01-18 2019-03-20 コデクシス， インコーポレイテッド カルバペネム合成に有用な人口生体触媒
EP2961844B1 (en) 2013-02-28 2018-09-26 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN103355405A (zh) * 2013-04-07 2013-10-23 苏州旭优食品科技有限公司 一种低过敏性含乳制品的加工工艺
EP3521423B1 (en) 2013-04-18 2021-07-21 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
JP6643987B2 (ja) 2013-11-13 2020-02-12 コデクシス， インコーポレイテッド ケトン化合物およびアミン化合物の還元的アミノ化のための操作されたイミンレダクターゼおよび方法
EP3928787A1 (en) 2014-04-16 2021-12-29 Codexis, Inc. Engineered tyrosine ammonia lyase
US9708587B2 (en) 2014-07-09 2017-07-18 Codexis, Inc. P450-BM3 variants with improved activity
JP6719463B2 (ja) 2014-11-25 2020-07-15 コデクシス， インコーポレイテッド ケトン化合物およびアミン化合物の還元的アミノ化のための操作されたイミンレダクターゼおよび方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US20170360900A1 (en) 2014-12-22 2017-12-21 Codexis, Inc. Human alpha-galactosidase variants
WO2016130412A1 (en) 2015-02-10 2016-08-18 Codexis, Inc. Ketoreductase polypeptides for the synthesis of chiral compounds
AU2016258091B2 (en) 2015-05-07 2020-10-01 Codexis, Inc. Penicillin-G acylases
DK3319987T3 (da) 2015-07-07 2021-06-21 Codexis Inc Nye p450-bm3-varianter med forbedret aktivitet
WO2017193022A1 (en) 2016-05-05 2017-11-09 Codexis, Inc. Penicillin-g acylases
IL263448B2 (en) 2016-06-09 2023-10-01 Codexis Inc Biocatalysts and methods for hydroxylation of chemical compounds
US11299723B2 (en) 2016-06-15 2022-04-12 Codexis, Inc. Engineered beta-glucosidases and glucosylation methods
SG11201900669WA (en) 2016-08-26 2019-03-28 Codexis Inc Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
JP7019202B2 (ja) 2017-01-05 2022-02-15 コデクシス， インコーポレイテッド ペニシリンｇアシラーゼ
US20180223264A1 (en) 2017-02-03 2018-08-09 Codexis, Inc. Engineered glycosyltransferases and steviol glycoside glucosylation methods
NZ755628A (en) 2017-02-13 2023-09-29 Codexis Inc Engineered phenylalanine ammonia lyase polypeptides
AU2018258274C1 (en) 2017-04-24 2021-12-02 Tesaro, Inc. Methods of manufacturing of niraparib
US11021729B2 (en) 2017-04-27 2021-06-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
SG11201909957TA (en) 2017-05-08 2019-11-28 Codexis Inc Engineered ligase variants
US11359183B2 (en) 2017-06-14 2022-06-14 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN117737045A (zh) 2017-06-27 2024-03-22 科德克希思公司 青霉素g酰化酶
CN119162145A (zh) 2017-06-30 2024-12-20 科德克希思公司 T7 rna聚合酶变体
KR20200023454A (ko) 2017-06-30 2020-03-04 코덱시스, 인코포레이티드 T7 rna 폴리머라제 변이체
WO2019094301A1 (en) 2017-11-07 2019-05-16 Codexis, Inc. Transglutaminase variants
JP7401435B2 (ja) 2017-12-13 2023-12-19 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド カルボキシエステラーゼ生体触媒
AU2018383752B2 (en) 2017-12-13 2025-01-30 Codexis, Inc. Carboxyesterase polypeptides for amide coupling
US10900055B2 (en) 2018-06-12 2021-01-26 Codexis, Inc. Engineered tyrosine ammonia lyase
MX2021000328A (es) 2018-07-09 2021-03-25 Codexis Inc Enzimas de variantes de galactosa oxidasa modificadas geneticamente.
US11162105B2 (en) 2018-07-09 2021-11-02 Codexis, Inc. Engineered purine nucleoside phosphorylase variant enzymes
JP7462969B2 (ja) 2018-07-09 2024-04-08 コデクシス， インコーポレイテッド 操作されたデオキシリボースリン酸アルドラーゼ
CN112673091A (zh) 2018-07-09 2021-04-16 科德克希思公司 工程化泛酸激酶变体酶
KR20210031933A (ko) 2018-07-09 2021-03-23 코덱시스, 인코포레이티드 조작된 포스포펜토뮤타제 변이체 효소
WO2020013951A1 (en) 2018-07-12 2020-01-16 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
MX2021001260A (es) 2018-07-30 2021-04-12 Tate & Lyle Solutions Usa Llc Glucosiltransferasas modificadas con ingenieria genetica y metodos de glucosilacion de glucosido de esteviol.
IL282456B1 (en) 2018-10-29 2025-03-01 Codexis Inc Engineered DNA polymerase variants
AU2019397401A1 (en) 2018-12-14 2021-06-17 Codexis, Inc. Engineered tyrosine ammonia lyase
BR112021011750A2 (pt) 2018-12-20 2021-08-31 Codexis, Inc. Alfa-galactosidase a recombinante e/ou fragmento de alfa-galactosidase a recombinante, composição, sequência de polinucleotídeo recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma variante de alfa-galactosidase a e para tratar e/ou prevenir os sintomas da doença de fabry, composição farmacêutica, e, uso das composições
CA3136828A1 (en) 2019-05-01 2020-11-05 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
SG11202110860SA (en) 2019-05-01 2021-10-28 Codexis Inc Engineered glucose dehydrogenases and methods for the reductive amination of ketone and amine compounds
EP4003061B1 (en) 2019-07-23 2024-04-24 FrieslandCampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
EP4501403A2 (en) 2019-08-30 2025-02-05 Société des Produits Nestlé S.A. Engineered lipase variants
EP4027969A4 (en) 2019-09-12 2023-09-27 Codexis, Inc. PEROXIDASE ACTIVITY AGAINST 10-ACETYL-3,7-DIHYDROXYPHENOXAZINE
CN114746745A (zh) 2019-10-02 2022-07-12 美国雅培糖尿病护理公司 通过蛋白质开关检测分析物
CA3165484A1 (en) 2019-12-20 2021-06-24 Codexis, Inc. Engineered acid alpha-glucosidase variants
CN116113691A (zh) 2020-02-04 2023-05-12 科德克希思公司 工程化亮氨酸脱羧酶
US11788071B2 (en) 2020-04-10 2023-10-17 Codexis, Inc. Engineered transaminase polypeptides
CN116897205A (zh) 2020-08-28 2023-10-17 科德克希思公司 工程化淀粉酶变体
BR112023003606A2 (pt) 2020-08-28 2023-03-28 Codexis Inc Protease recombinante, composição, sequência polinucleotídica recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma protease recombinante e para tratar e/ou prevenir os sintomas de insuficiência pancreática, e, uso
CA3201757A1 (en) 2020-12-11 2022-06-16 Mathias Schuetz Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors
JP2024500102A (ja) 2020-12-18 2024-01-04 コデクシス， インコーポレイテッド 操作されたウリジンホスホリラーゼ改変体酵素
CA3214975A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered cyclic gmp-amp synthase (cgas) variant enzymes
CN117222735A (zh) 2021-04-02 2023-12-12 科德克希思公司 工程化乙酸激酶变体酶
IL305922A (en) 2021-04-02 2023-11-01 Codexis Inc Engineered guanylate kinase variant enzymes
US11913037B2 (en) 2021-04-02 2024-02-27 Codexis, Inc. Engineered adenylate kinase variant enzymes
CA3220735A1 (en) 2021-05-21 2022-11-24 Codexis, Inc. Engineered methionine gamma lyase variants
EP4377451A2 (en) 2021-07-30 2024-06-05 Willow Biosciences, Inc. Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids
WO2023023621A1 (en) 2021-08-19 2023-02-23 Willow Biosciences, Inc. Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids
CN118103501A (zh) 2021-10-15 2024-05-28 科德克希思公司 工程化dna聚合酶变体
WO2023069921A1 (en) 2021-10-19 2023-04-27 Epimeron Usa, Inc. Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids
CN116891839A (zh) 2022-03-31 2023-10-17 青岛清原化合物有限公司 一种单胺氧化酶及其应用
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
WO2024150146A1 (en) 2023-01-12 2024-07-18 Novartis Ag Engineered ketoreductase polypeptides

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886288A (en) * 1970-06-15 1975-05-27 Swift & Co Cheese manufacture using highly active proteolytic enzymes
JPS5279086A (en) 1975-12-25 1977-07-02 Nippon Soda Co Ltd Preparation of antibiotic tunicamycin
JPS5279083A (en) * 1975-12-26 1977-07-02 Morinaga Milk Industry Co Ltd Production of protein decomposed substance not having bitterness and antigen property
JPS6041751B2 (ja) 1976-06-22 1985-09-18 ジエコ−株式会社 デジタル電子時計
JPS548785A (en) 1977-06-21 1979-01-23 Kikkoman Corp Preparation of protein hydrolyzate
US4839281A (en) † 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK589785A (da) 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
EP0322589B1 (fr) † 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
DD281540A5 (de) * 1988-08-08 1990-08-15 Berlin Chemie Veb Verfahren zur herstellung von nutritiva
ES2063882T5 (es) † 1989-10-02 2001-12-01 Novartis Nutrition Ag Hidrolizados de proteinas.
JP3071877B2 (ja) † 1991-06-27 2000-07-31 財団法人糧食研究会 経口寛容誘導能を有する低アレルゲン性酵素分解ペプチド組成物
US5952034A (en) * 1991-10-12 1999-09-14 The Regents Of The University Of California Increasing the digestibility of food proteins by thioredoxin reduction
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
FI94089C (sv) 1992-12-10 1995-07-25 Valio Oy Förfarande för avlägsning av allergiframkallande föreningar ur proteinhaltiga sammansättningar
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
GB9312369D0 (en) * 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
AU1076595A (en) † 1993-11-23 1995-06-13 Kabushiki Kaisha Wado Doctors Group Intestinal flora improver composition, and apparatus and system for producing the same
FI104465B (sv) * 1995-06-14 2000-02-15 Valio Oy Proteinhydrolysat för behandling och förebyggande av allergier samt framställning och användning av dessa

Also Published As

Publication number Publication date
DE69625690D1 (de) 2003-02-13
DK0833649T4 (da) 2009-07-20
ZA965088B (en) 1997-01-22
BR9607827A (pt) 1999-11-30
US20030113340A1 (en) 2003-06-19
DE69625690T3 (de) 2009-12-24
DK0833649T3 (da) 2003-04-07
AU710126B2 (en) 1999-09-16
FI104465B (sv) 2000-02-15
ES2191103T5 (es) 2009-11-03
EP0833649A1 (en) 1998-04-08
CZ291904B6 (cs) 2003-06-18
MY113912A (en) 2002-06-29
AU6127896A (en) 1997-01-15
DE69625690T2 (de) 2003-11-06
PL324010A1 (en) 1998-04-27
NZ310478A (en) 2000-01-28
BG63153B1 (bg) 2001-05-31
ES2191103T3 (es) 2003-09-01
KR19990022914A (ko) 1999-03-25
EE9700339A (et) 1998-06-15
MX9710109A (es) 1998-10-31
CN1154506C (zh) 2004-06-23
CA2224320C (en) 2012-03-20
AR003960A1 (es) 1998-09-30
NO321504B1 (no) 2006-05-15
BG102144A (en) 1998-12-30
JP3983804B2 (ja) 2007-09-26
PL185123B1 (pl) 2003-02-28
EE03424B1 (et) 2001-06-15
SK284245B6 (sk) 2004-12-01
CZ399797A3 (cs) 1998-06-17
US6506380B1 (en) 2003-01-14
US7172756B2 (en) 2007-02-06
FI952926A0 (sv) 1995-06-14
ATE230606T1 (de) 2003-01-15
EP0833649B2 (en) 2009-06-03
JPH11510791A (ja) 1999-09-21
CN1187772A (zh) 1998-07-15
EP0833649B1 (en) 2003-01-08
IL122577A0 (en) 1998-06-15
HK1010081A1 (en) 1999-06-11
NO975832L (no) 1997-12-11
RO120243B1 (ro) 2005-11-30
NO975832D0 (no) 1997-12-11
SK171597A3 (en) 1998-11-04
WO1997000078A1 (en) 1997-01-03
KR100494741B1 (ko) 2005-09-30
CA2224320A1 (en) 1997-01-03

Similar Documents

Publication Publication Date Title
FI952926L (sv) Förfaranden för behandling och förebyggande av allergies
DE69521363D1 (de) Hautalterungsschutzmittel
FI964087L (sv) Byxblöja eller byxbinda
DE69617372D1 (de) Datenaufzeichnungs-/-wiedergabeverfahren
NO974849D0 (no) Supermartensittisk stål
PT858464E (pt) Inibidores de trombina
FI971568L (sv) Förfarande för behandling av resistenta tumörer
DE69627579D1 (de) Personenidentifizierungssystem
NO950617D0 (no) Sikkerhetssystem
FI973529L (sv) Askomysiner
DE19681419T1 (de) Behandlungssystem
NO960227L (no) Sikkerhetssystem
NO982911D0 (no) FremgangsmÕte for behandling av depresjon
BR9606678A (pt) Processo de metalurgia
PT863916E (pt) Tripeptidos de polifluoroalquil triptofano inibidores de trombina
FI971675L (sv) Förfarande för att inhibera tillstånd som associeras med bradykinin
FI953878L (sv) Förfarande för att förhindra och inhibera befruktning
DE69611224D1 (de) Verringerung von videomoire
DE69607764D1 (de) Induktives bauelement
FI973521A0 (sv) Metoder för förebyggande av äggstockcancer
BR9610514A (pt) Inibidores cicloantihelmínticos
FI102791B1 (sv) Induktiv komponent
IT1268611B1 (it) Coprocessore per riconoscimento caratteri
NO973629D0 (no) Sikkerhetssystem
FI964843A0 (sv) Förfarande för behandling av massa

Legal Events

Date Code Title Description
MA Patent expired